Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

[Hepatic arterial infusion chemotherapy with oxaliplatin in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure].

Tsuchiya M, Watanabe M, Koike J, Kubota Y, Suzuki T, Otsuka Y, Tamura A, Maeda T, Shiokawa H, Arai K, Kurihara A, Funahashi K, Shimada H, Kaneko H.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2594-7. Japanese.

PMID:
21224650
2.

Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.

Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M, Ducreux M.

Ann Surg Oncol. 2008 Jan;15(1):219-26. Epub 2007 Sep 26.

PMID:
17896145
3.

Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

Ducreux M, Ychou M, Laplanche A, Gamelin E, Lasser P, Husseini F, Quenet F, Viret F, Jacob JH, Boige V, Elias D, Delperro JR, Luboinski M; gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

J Clin Oncol. 2005 Aug 1;23(22):4881-7. Epub 2005 Jul 11.

PMID:
16009952
4.
5.

Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.

Guan M, Chen SC, Ying HY, Zhao L, Li XY, Zhou JF, Shao YJ, Yang XD, Lin Y, Ning XH, Bai CM.

Chin Med J (Engl). 2012 Oct;125(20):3640-5.

PMID:
23075717
6.

Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.

Goéré D, Deshaies I, de Baere T, Boige V, Malka D, Dumont F, Dromain C, Ducreux M, Elias D.

Ann Surg. 2010 Apr;251(4):686-91. doi: 10.1097/SLA.0b013e3181d35983.

PMID:
20224373
7.

Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.

Link KH, Kornmann M, Leder G, Pillasch AF, Sunelaitis E, Schatz M, Pressmar J, Beger HG.

Gan To Kagaku Ryoho. 1999 Feb;26(3):269-81. Review.

PMID:
10065089
8.

Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases.

Samaras P, Breitenstein S, Haile SR, Stenner-Liewen F, Heinrich S, Feilchenfeldt J, Renner C, Knuth A, Pestalozzi BC, Clavien PA.

Ann Surg Oncol. 2011 Jul;18(7):1924-31. doi: 10.1245/s10434-010-1505-2. Epub 2011 Jan 5.

PMID:
21207165
9.

Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.

Goéré D, Benhaim L, Bonnet S, Malka D, Faron M, Elias D, Lefèvre JH, Deschamps F, Dromain C, Boige V, Dumont F, De Baere T, Ducreux M.

Ann Surg. 2013 Jan;257(1):114-20. doi: 10.1097/SLA.0b013e31827b9005.

PMID:
23235397
10.

Hepatic arterial infusion of oxaliplatin, 5-fluorouracil and leucovorin in patients with liver metastases from colorectal carcinoma.

Melichar B, Ferko A, Krajina A, Rousková L, Dvorák J, Svébisova H, Neoral C, Köcher M, Malirová E, Paral J.

J BUON. 2012 Oct-Dec;17(4):677-83.

PMID:
23335524
11.

Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.

Tsutsumi S, Yamaguchi S, Tsuboi K, Fukasawa T, Tabe Y, Asao T, Kuwano H.

Hepatogastroenterology. 2008 Jul-Aug;55(85):1419-22.

PMID:
18795703
12.

Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases.

Neyns B, Van Nieuwenhove Y, Aerts M, Fontaine C, Vermeij J, Schallier D, Decoster L, De Mey J, Vandenbroucke F, Hoorens A, Delvaux G, De Gréve J.

Anticancer Res. 2006 Jan-Feb;26(1B):611-9.

13.

Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.

Kemeny N, Jarnagin W, Paty P, Gönen M, Schwartz L, Morse M, Leonard G, D'Angelica M, DeMatteo R, Blumgart L, Fong Y.

J Clin Oncol. 2005 Aug 1;23(22):4888-96. Epub 2005 Jul 11.

PMID:
16009951
14.

Efficacy and safety of hepatic arterial infusion of fluorouracil with leucovorin as salvage treatment for refractory liver metastases from colorectal cancer.

Lee HJ, Lee YS, Lee KW, Kim SY, Yoon CJ, Shin DY, Lee YG, Choi SY, Kang SG, Kang SB, Kim JH.

Korean J Intern Med. 2011 Mar;26(1):82-8. doi: 10.3904/kjim.2011.26.1.82. Epub 2011 Mar 2.

15.

Comparison of complete pathologic response and hepatic injuries between hepatic arterial infusion and systemic administration of oxaliplatin in patients with colorectal liver metastases.

Allard MA, Sebagh M, Baillie G, Lemoine A, Dartigues P, Faitot F, Faron M, Boige V, Vitadello F, Vibert E, Elias D, Adam R, Goéré D, Sa Cunha A.

Ann Surg Oncol. 2015;22(6):1925-32. doi: 10.1245/s10434-014-4272-7. Epub 2014 Dec 2.

PMID:
25448804
16.

Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.

Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghémard O, Levi F, Bismuth H.

Ann Surg. 2004 Oct;240(4):644-57; discussion 657-8.

17.

Phase I trial of hepatic arterial infusion (HAI) of floxuridine with modified oxaliplatin, 5-fluorouracil and leucovorin (m-FOLFOX6) in Chinese patients with unresectable liver metastases from colorectal cancer.

Li C, Gu Y, Zhao M, Yuan Y, Wang F, Wang Z, Li W, Luo H, Chen C, Chen G, Ding P, Wu X, Lu Z, Pan Z, Xu R, He Y, Wan D, Li Y.

Cancer Chemother Pharmacol. 2014 Nov;74(5):1079-87. doi: 10.1007/s00280-014-2585-7. Epub 2014 Sep 13.

PMID:
25217393
18.

Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.

Guthoff I, Lotspeich E, Fester C, Wallin I, Schatz M, Ehrsson H, Kornmann M.

Anticancer Res. 2003 Nov-Dec;23(6D):5203-8.

PMID:
14981990
19.

Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.

Del Freo A, Fiorentini G, Sanguinetti F, Muttini MP, Pennucci C, Mambrini A, Pacetti P, Della Seta R, Lombardi M, Torri T, Cantore M.

In Vivo. 2006 Nov-Dec;20(6A):743-6.

20.

The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial.

Mosconi S, Cascinu S, Zaniboni A, Catalano V, Giordani P, Beretta GD, Martignoni G, Pancera G, Baldelli AM, Poletti P, Curti C, Labianca R.

Tumori. 2000 Nov-Dec;86(6):465-9.

PMID:
11218187

Supplemental Content

Support Center